JUN 14, 2017 1:56 PM PDT

One Gene and Its Role in Heart Disease

WRITTEN BY: Kara Marker

Environmental and lifestyle factors are key in the development of heart disease, a malady that affects a monumental amount of people every year. But a new study instead focuses on the genetic side of heart disease causation, identifying a gene mutation that might be responsible for the mostly-unexplained heart condition hypertrophic cardiomyopathy.

Micrograph of a heart with fibrosis (yellow) and amyloidosis (brown). Credit: Simple Wikipedia 

A mutated gene, OBSCN, causes an irregular heartbeat that makes the muscle work harder to pump blood to deliver oxygen and nutrients to the body’s tissue, increasing the risk for heart failure. From the University of Maryland School of Medicine, the discovery of this mutation and its connection to heart disease is one nearly twenty years in the making. 

OBSCN is a gene that produces signaling proteins called obscurins, large cytoskeletal proteins with structural and regulatory roles such as the organization of myofibrils, contractile threads within muscle cells. In addition to hypertrophic cardiomyopathy, OBSCN mutations are linked to increased risk of many types of cancer and congenital heart disease.

Despite these known links, researchers have yet to pinpoint the precise mechanisms by which an OBSCN mutation causes disease. The gene itself was first discovered by scientists in 2011, including Dr. Aikaterini Kontrogianni-Konstantopoulos from the University of Maryland, senior author of the new study linked OBSCN mutations to hypertrophic cardiomyopathy (HCM).

HCM is a condition characterized by an enlarged heart - visible from measurements and weight, muscle thickened and scarred - that becomes less efficient at pumping blood. It is one of four types of cardiomyopathy, a general dysfunction of the heart muscle that develops often for unknown reasons. HCM is typically a familial disorder caused by different gene mutations and resulting in a variety of disease outcomes.

Kontrogianni-Konstantopoulos created a genetically altered mouse model of the OBSCN mutation to study its effects on the heart in more detail. There were three experimental groups receiving different levels of stress: none, moderate, and significant. Groups experience zero stress simply developed an arrhythmia, those experiencing moderate stress showed signs of thickened hearts, and those experiencing significant stress scarred and ineffective hearts.

There is still much to uncover about the mechanisms by which genetic mutations in OBSCN ultimately lead to heart disease, and the present study represents the first steps toward understanding the details of this genetic factor of heart disease.

The present study was published in the journal Science Advances.

Sources: Oncogene, National Center for Biotechnology Information, Hypertrophic Cardiomyopathy Association, University of Maryland School of Medicine

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 07, 2019
Clinical & Molecular DX
NOV 07, 2019
A Revealing Look at Rare Disease Incidence
Being diagnosed with a rare disease can be especially terrifying for patients. After all, many of these diseases have no ...
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
Experimental Cholesterol-Lowering Drug
A recent study shows that patients who take a maximum dose of statin drugs in addition to a twice-yearly injection of th ...
FEB 07, 2020
Cardiology
FEB 07, 2020
Eating Red and Processed Meats Increases Heart Disease Risk
Although the link between consuming processed meats and an increased risk of cardiovascular disease (CVD) is well establ ...
MAR 20, 2020
Drug Discovery & Development
MAR 20, 2020
WHO Says Ibuprofen May Still Work Against COVID-19
Since the announcement of a French Health Minister in recent days linking usage of ibuprofen and other non-steroidal ant ...
MAR 25, 2020
Cardiology
MAR 25, 2020
Exclusive Breastfeeding Promotes Moms Heart Health
New mothers face a vast number of choices as they welcome the new child into the world. One such choice is how to feed t ...
APR 25, 2020
Cardiology
APR 25, 2020
Young People with COVID-19 Die from Stroke
Hospitals around the US have reported that people aged between 20 and 50 with no risk factors are dying from strokes aft ...
Loading Comments...